"adverse events" trang 3 - tải miễn phí từ tailieunhanh
Adverse drug events and medication relation extraction in electronic health records with ensemble deep learning methods

Adverse drug events and medication relation extraction in electronic health records with ensemble deep learning methods
8    2    1
Predicting potential adverse events using safety data from marketed drugs

Predicting potential adverse events using safety data from marketed drugs
21    57    1
Adverse events after manual therapy among patients seeking care for neck and/or back pain: A randomized controlled trial

Adverse events after manual therapy among patients seeking care for neck and/or back pain: A randomized controlled trial
10    45    1
Prospective correlation between the patient microbiome with response to and development of immune-mediated adverse effects to immunotherapy in lung cancer

Prospective correlation between the patient microbiome with response to and development of immune-mediated adverse effects to immunotherapy in lung cancer
14    51    1
Rhabdomyolysis associations with antibiotics: A pharmacovigilance study of the FDA adverse event reporting system (FAERS)

Rhabdomyolysis associations with antibiotics: A pharmacovigilance study of the FDA adverse event reporting system (FAERS)
6    76    0
Clostridium difficile infection risk with important antibiotic classes: An analysis of the FDA adverse event reporting system

Clostridium difficile infection risk with important antibiotic classes: An analysis of the FDA adverse event reporting system
6    84    0
The incidence of collagen-associated adverse events in pediatric population with the use of fluoroquinolones: A nationwide cohort study in Taiwan

The incidence of collagen-associated adverse events in pediatric population with the use of fluoroquinolones: A nationwide cohort study in Taiwan
11    59    0
Characterization and preventability of adverse drug events as cause of emergency department visits: A prospective 1-year observational study

Characterization and preventability of adverse drug events as cause of emergency department visits: A prospective 1-year observational study
11    73    0
Development of a mortality score to assess risk of adverse drug reactions among hospitalized patients with moderate to severe chronic kidney disease

Development of a mortality score to assess risk of adverse drug reactions among hospitalized patients with moderate to severe chronic kidney disease
11    77    0
Characterization of serious adverse drug reactions as cause of emergency department visit in children: A 5-years active pharmacovigilance study

Characterization of serious adverse drug reactions as cause of emergency department visit in children: A 5-years active pharmacovigilance study
8    63    0
Challenges in diagnosis and management of neutropenia upon exposure to immunecheckpoint inhibitors: Meta-analysis of a rare immune-related adverse side effect

Challenges in diagnosis and management of neutropenia upon exposure to immunecheckpoint inhibitors: Meta-analysis of a rare immune-related adverse side effect
15    75    0
Possible involvement of interleukin-18 in the pathology of hepatobiliary adverse effects related to treatment with ceritinib

Possible involvement of interleukin-18 in the pathology of hepatobiliary adverse effects related to treatment with ceritinib
4    66    0
Severe colitis after PD-1 blockade with nivolumab in advanced melanoma patients: Potential role of Th1-dominant immune response in immune-related adverse events: Two case reports

Severe colitis after PD-1 blockade with nivolumab in advanced melanoma patients: Potential role of Th1-dominant immune response in immune-related adverse events: Two case reports
7    55    0
Radiotherapy-induced anti-tumor immune response and immune-related adverse events in a case of recurrent nasopharyngeal carcinoma undergoing anti-PD-1 immunotherapy

Radiotherapy-induced anti-tumor immune response and immune-related adverse events in a case of recurrent nasopharyngeal carcinoma undergoing anti-PD-1 immunotherapy
7    69    1
Efficacy of anti-PD-1/PD-L1 antibodies after discontinuation due to adverse events in non-small cell lung cancer patients (HANSHIN 0316)

Efficacy of anti-PD-1/PD-L1 antibodies after discontinuation due to adverse events in non-small cell lung cancer patients (HANSHIN 0316)
6    36    1
Belotecan/cisplatin versus etoposide/ cisplatin in previously untreated patients with extensive-stage small cell lung carcinoma: A multi-center randomized phase III trial

Belotecan/cisplatin versus etoposide/ cisplatin in previously untreated patients with extensive-stage small cell lung carcinoma: A multi-center randomized phase III trial
9    51    1
Correlation analyses between pre and post-operative adverse events in gastric cancer patients receiving preoperative treatment and gastrectomy

Correlation analyses between pre and post-operative adverse events in gastric cancer patients receiving preoperative treatment and gastrectomy
11    67    1
Use and misuse of common terminology criteria for adverse events in cancer clinical trials

Use and misuse of common terminology criteria for adverse events in cancer clinical trials
6    46    1
Knowledge-based extraction of adverse drug events from biomedical text

Knowledge-based extraction of adverse drug events from biomedical text
8    51    1
Perceived occurrence of an adverse event affects patient-reported outcomes after total hip replacement

Perceived occurrence of an adverse event affects patient-reported outcomes after total hip replacement
8    40    1